Podcasts about Pharma

101521 SHORTCAST 5 MIN What Happened in Pharma & Public Health Is SO Important To Understand by Kate Dalley

Episode 42 of the pharmaphorum podcast heard from Catherine Owen, who's senior vice president of major markets at Bristol Myers Squibb, about the future of pharma commercialisation and communications.

Gene therapy has come a long way to get where it is today but there is still much to learn and investigate. Host Adam Rutherford speaks to a line-up of experts about the vital role of clinical trials and the unique challenges facing gene therapy and rare disease patients. Featuring guests:Professor John Rasko, Clinical Haematologist & Trial Investigator, University of SydneySuneet Varma, Global President, Rare Disease, PfizerEmily Crossley, Chief Executive Officer, Duchenne UKBrenda Cooperstone, Senior Vice President, Chief Development Officer, Rare Disease, PfizerSimone Boselli, Director, Public Affairs, EURORDISErik Paulsen, Chair, Institute for Gene Therapies

In this Outcomes Rocket Pharma episode, we are privileged to host the outstanding Blake Mandell, co-founder and President of Transcend Therapeutics which discovers, develops, and delivers next-generation medicines to work towards a world in which people no longer suffer from the neuropsychiatric disease. Blake discusses how his company Carly explains how her work has an opportunity to improve patient experience on many levels. She highlights some of the changes happening in terms of patient care in the pharma space like the move towards holistic, patient-centered care and partnerships with innovation organizations to meet customer needs. She also talks about some of the programs of Moda Health in supporting communities, therapeutic advancements made, the biggest challenges facing the pharma industry, and more. This is a great conversation on patient-centric care in the Pharma space, so please tune in!

Joe Manchin's daughter is a price gouging big pharma CEO. His wife isn't much better. What does this tell us about him? What does it mean for the Senate? We're on YOUTUBE: https://www.youtube.com/channel/UCt7_0g7BGxSoifvX8_gx4TA iTunes: http://apple.co/2tCd0Dn Google Play: shorturl.at/uCFN2 Stitcher: http://www.stitcher.com/s?fid=139322 TuneIn: http://bit.ly/2svIk6F ... and now Spotify! https://spoti.fi/2NpeIT3 Please subscribe, share us with your friends and write a review! Follow us on Twitter @BestWordsPod

Robert Yoho spent three decades as a cosmetic surgeon after a career as an emergency physician. He's the author of Butchered by Healthcare. We talk about his dealings with hospitals, big Pharma, insurance companies, and much more.   Connect w/ Robert: https://www.robertyohoauthor.com/  

Swipe right on... Twirla? Creating ads for a contraceptive patch on dating apps is emblematic of the innovative approach that Amy Welsh, the Vice President of Marketing takes at Agile Therapeutics. Welsh has no shame in working with marketing agencies to utilize the advantages that they offer, while also maintaining close control of her brand's integrity.  It's safe to say, Welsh has no shame in taking a different approach that spurs traditional marketing tactics“The novel -- the different ways of doing it -- is strategic media partnering,” Welsh said. “For instance, [at Agile] we were able to be the first contraceptive to advertise on dating apps like Match. I couldn't have done that if I didn't have somebody outside who was street-smart, and partnered with us to appropriately come up with a plan for that.” Welsh continued,  “I want to ensure that the marketing team is the brand steward. We better know our brand better than everybody. And I want to use my agency for things that I don't know or can't do. It's a bit of a hybrid but the marketing team better be the brand stewards and the strategists a hundred percent.”Launching a contraceptive in the middle of 2020 might not have been the tactical dream for Welsh, but she did it anyway. Welsh has alway acted quick on her feet. It's part of what makes him a good marketer and it's part of what made this conversation with her so fun.Throughout her career in big and small pharma Amy's launched many products and is a fountain of wisdom for having had all that experience. As she creates a new team, for a new company, in a new product market, her thirst to innovate is high. She's found a need to create new roles for people who can specialize in marketing on popular new tools and apps. On this episode of Marketing Trends, Welch explains the unique challenges of marketing to Gen Z as well as creating awareness for an entire product class; she also talks about how she is creating new roles on her marketing team. I hope you enjoy this episode.Main TakeawaysMarketing to Gen Z: New iterations of media modalities require tailored marketing tactics. Marketers are treading water and testing out the best ways to market to this upcoming generation. Thinks that worked for millenials, don't necessarily work on a younger generations with different values and needs. Getting in front of your audience via advertising on apps and other new media, is the way of today. Campaigns that are Purely Educational: When your product market is so young, and largely unknown to your target audience, you've got to embark on some educational campaigns. You've also got to listen, which means asking the right questions -- actually talking to people so you can learn what they are looking for and gathering feedback and data from those conversations is priceless for marketers. It's a brandless campaign that's teaching consumers about what it is and it's an important foundation for marketing in a product field. Creatively Building Teams: Sometimes the positions that you need filled don't really match with traditional job descriptions. As new needs in new markets arise, CMO's and VP's of Marketing are creating new roles in their teams to address advertising on new social media platforms. Marketing Needs to Learn from Sales: Market research, focus groups and other methods of gathering information about your audience are all helpful but if you have sales reps that you can talk about the reaction and perception of your product to your customers, you can learn so much about what you're doing right and how you need to shift to address the needs of your customer better.Key Quotes“This felt like an opportunity to authentically connect and not push the brand. Pharma loves to push our agenda. Let's just sit and build a community and listen, ‘Does she even know patches exist?' or ‘Does she know 15 or more options exist?' And almost even more importantly, ‘Does she know things are changing? t the time, the ACA allows you to get any one of these options for free,' so we started this campaign, shortly after I got on board in the middle of the summer called the ‘I'm so Done' campaign where we just really wanted to have some fun and educate, and build a community before we were going to be all in.” “[In this industry] understanding Planned Parenthood and Student Health Clinics [which] are big in my world and the different marketing challenges there [are critical.] How do you make yourself meaningful there? It's telemedicine, but bigger than telemedicine. It's understanding the digital entrepreneurial world. What are the new businesses out there and what's next for either Twirla or Agile? Because we're not just a patch company, we're a women's health company.” “The novel -- the different ways of doing it -- that is strategic media partnering. For instance, we were able to be the first contraceptive to advertise on dating apps like Match. I couldn't have done that if I didn't have somebody outside who was street-smart, and partnered with us to appropriately come up with a plan for that. I want to ensure that the marketing team is the brand steward. We know our brand better than everybody. And I want to use my agency for things that I don't know or can't do. It's a bit of a hybrid, but the marketing team better be the brand stewards and the strategists a hundred percent.”“I only have so many dollars, so every bit of it better go to the person that actually can and will consider my product. In the beginning for Twirla, my challenge was to let [the consumer] know that a patch even exists as a birth control option. And a patch named Twirla is the better option for you to consider. Twirla is not only getting new patients, but they're all staying (no pun intended), they're sticking with us. For the first year, I needed to make sure that everything we were doing was firing on all cylinders against the right eyeballs and no wasted space.” “You have people that may defer to timelines rather than thought. You have people that worry about budget -- you should always worry about budget -- but [they] maybe sit on a big idea that could have advanced things. So, how do you set up an atmosphere [respecting] the budget, but [also] let's talk about something that we love every month. Let's talk about something that we were inspired by every week.”To learn more, click here: {{URL of detail page on found on www.mission.org}}---Marketing Trends podcast is brought to you by Salesforce. Discover marketing built on the world's number one CRM: Salesforce. Put your customer at the center of every interaction. Automate engagement with each customer. And build your marketing strategy around the entire customer journey. Salesforce. We bring marketing and engagement together. Learn more at salesforce.com/marketing. 

Dental podcast: Welcome to DentalTalk. I'm Dr. Phil Klein. Today we'll be focusing on new techniques and research in local anesthesia and how articaine can help you get your patients comfortably numb faster and more efficiently. Our guest is Dr. David Isen, who runs a private practice in Toronto called Sleep For Dentistry, which treats patients with anesthetic and medical challenges. Dr. Isen is a published author and past consultant for dental and pharmaceutical companies.

This episode features the brilliant Jessica Benstock who is a trauma & energy healer and leadership mentor to entrepreneurs. In this episode we discuss alternative medicine vs. western medicine, the marketing of big Pharma, and opportunities for health professionals to dive deeper in order to get to the root cause of medical conditions. Jessica opens up about her experience with rape, STD's and her healing journey using alternative medicine. *Trigger Warning* Follow Jessica here: https://www.instagram.com/jessica.benstock/ Check out my first conversation with Jessica (episode 34 on the Just Keep Thriving Podcast).

Graham and Alex are back with a jam-packed episode from the thick of R1 application activity. This week's episode kicks off with a breakdown of last week's Harvard interview invitations - and why getting rejected may not spell the end of one's quest for a top MBA. Our hosts then turn their attention to the return of Clear Admit's Real Humans (featuring Michigan Ross) and to the recently published Class of 2023 Profile for UVA Darden. Of course, it wouldn't be WireTaps without a few candidate profile reviews, so this week Alex and Graham explore the potential challenges facing an impressive pharma candidate targeting VC for a post-MBA job, an SEO/digital marketer's entrepreneurial struggles during COVID, and an important debate over the merits of a 690 GMAT vs. a 322 GRE score. As usual, this week's episode was recorded near the beach in Cornwall, England, and in the shadow of the Sacre Coeur in Montmartre, Paris. It was painstakingly produced by Dennis Crowley in 'always sunny' Philadelphia. Please remember to rate and review the show, and to convince at least 10 other people to become regular listeners!

Raven Liddle, joins the program to discuss the collapse of our food system. How the food supply is causing a real pandemic of disease and obesity that is slowly killing humanity while enriching big pharma and serving the interests of globalists. We discuss how you can combat this agenda and take back control of your own food supply and regain high nutrition and health. It's time to draw the line!

To become a Breaking Points Premium Member and watch/listen to the show uncut and 1 hour early visit: https://breakingpoints.supercast.com/To listen to Breaking Points as a podcast, check them out on Apple and SpotifyApple: https://podcasts.apple.com/us/podcast/breaking-points-with-krystal-and-saagar/id1570045623Spotify: https://open.spotify.com/show/4Kbsy61zJSzPxNZZ3PKbXlMerch: https://breaking-points.myshopify.com/

Gene therapy is a revolutionary field of science that has the potential to transform lives. It presents this big question; What if we could treat a disease at its root cause, rather than just the symptoms? On the first episode of Science Will Win, host Adam Rutherford takes us through the history, science, and significance of gene therapy.Featuring guests:Laurence Woollard, Director, On The Pulse ConsultancyDirk Vander Mijnsbrugge, Vice President, Medical Affairs, Rare Diseases, PfizerSonal Bhatia, Chief Medical Officer, Rare Disease, PfizerDurhane Wong-Rieger, President & CEO at Canadian Organization for Rare Disorders

In this podcast, Yan Kugel and our guest Megann Löffler talk about the new trends in the pharmaceutical industry, what you need to know about the market and what the companies are looking for. Her experience in the recruitment field enables her to give valuable insights that will potentially help you to build a successful career in the future. Who Is Megan Löffler? With an educational background in engineering coupled with an HR degree, Megann is currently working as a Talent Acquisition Manager at Headcount AG. It is a Zürich based consultancy serving clients in the pharmaceutical and biotechnology market segments. Megan has been working as a recruiter for six years, specializing in Pharma since the very start of her career. She is now building up her team within headcount and embracing management responsibilities and technical operations positions. Listening to the Podcast, You Will Learn About: ● Innovations in the Pharmaceutical Industry ● Effect of New Developments on Recruiting Process ● Challenges for the New People in the Industry ● What Are Pharmaceutical Companies Looking for? ------------------------------------------------------------------------------------------------------ Watch or read the full podcast and read the article at www.podcast.qualistery.com/how-to-build-a-successful-career-in-the-pharma-of-tomorrow ------------------------------------------------------------------------------------------------------ This episode is Sponsored by Dot Compliance, the industry's first ready-to-use Quality Management Solution powered by the SalesForce platform. Implementation of a new eQMS has never been quicker nor easier. #Pharma #GMP #Pharmaceutical #Pharmaceuticalmanufacturing

DLA Piper partners Ellen Scordino and Susan Krumplitsch are joined by Duane Valz, General Counsel of Insitro, to discuss how machine learning is being used to generate and leverage data for the development of better medicines.

Maia Brenner (AI Specialist & Head of Business Development @ Tryolabs) shares the fundamentals to begin your company's AI/ML journey! We cover the most common challenges & pitfalls eng leaders face when investing in AI, how to understand feasibility/impact & ROI of different AI/ML initiatives, how to build your AI roadmap, how to break down massive AI/ML projects into small experiments, and how to accelerate different phases of your AI/ML strategy with partners like Tryolabs. ABOUT MAIA BRENNER Maia Brenner is a passionate data scientist and economist with strong programming skills, a mathematical and statistical background, and work experience in consulting and the public sector. As an AI Specialist at Tryolabs she helps clients maximize the full potential of data science and machine learning to solve their business problems. Maia's experience in the consulting industry covers several projects related to demand forecasting, price optimization, customer segmentation, and natural language processing applications, among others. As a technical consultant, she has helped design and develop AI solutions for companies from several different industries such as Retail, Finance, Pharma, Logistics, Transportation, Hospitality, Education, and more. She is also a professor in several universities and enjoys working on initiatives of AI4SocialGood. She has helped in the application of Machine Learning to improve the Public Education sector and is involved in Gender Inequality research groups. SHOW NOTES The origin story behind Tryolabs (2:33) Common AI/ML challenges Tryolabs helps solve (5:48) Most painful problems with building AI capabilities (7:50) What are the fundamentals to build an AI organization? (10:11) How do you integrate AI/ML into your core business? (12:42) What problems can (or can't) be solved with AI/ML? (15:18) How Tryolabs helps companies to identify specific AI/ML use cases (16:59) Common pitfalls when investing in & integrating AI/ML into your company (18:19) How to start small & experiment with AI/ML solutions (20:14) How Tryolabs scopes & iterates their AI/ML projects (24:42) Metrics, KPIs & other ways to determine feasibility, impact & ROI of your AI/ML project (26:53) How to build an AI/ML roadmap for your organization (30:34) How Tryolabs accelerates building your AI organization (34:28) --- Ready to own your AI Strategy? Learn more about Tryolabs HERE: https://bit.ly/39QpNoH --- Send in a voice message: https://anchor.fm/engineeringleadership/message

In this episode of By Any Means Necessary, hosts Sean Blackmon and Jacquie Luqman are joined by international affairs and security analyst Mark Sleboda to discuss the revelations of the recently released Pandora papers and the curious absence of the US elite and politicians, the Guardian's misleading implication of Vladimir Putin's involvement, and the US participation in hiding wealth, particularly in Joe Biden's home state of Delaware.In the second segment, Sean and Jacquie are joined by Dr. Mike Pappas, a family medicine physician, activist, and frequent contributor to LeftVoice.org to discuss the superprofits that the pharmaceutical industry makes off of necessary, life-saving drugs used for common illnesses, the moral bankruptcy of a system that rakes in billions of dollars from people being sick, and how the corporate political duopoly upholds such cruelty.In the third segment, Sean and Jacquie are joined by Bob Schlehuber, co-host of Political Misfits, on from 12-2 PM EST to discuss The Many Saints of Newark, a prequel film to The Sopranos television series, the themes of the rot in American society that the Sopranos series and the Many Saints of Newark reflects, how the show has aged well in representations of mental health and prescription drugs, and the hollow representations of Black people in the prequel film.Later in the show, Sean and Jacquie are joined by Walter Smolarek, a journalist and activist editor of Liberation newspaper, and managing editor of LiberationNews.org to discuss Joe Manchin and Kyrsten Sinema's stonewalling of the budget bill and the Democrats' refusal to push for reforms that will provide much needed benefits to working and poor people, the US continued economic and propaganda war on China, and how capitalism contributed to the now 700,000 dead from COVID-19.

In this segment of By Any Means Necessary, Sean and Jacquie are joined by Dr. Mike Pappas, a family medicine physician, activist, and frequent contributor to LeftVoice.org to discuss the superprofits that the pharmaceutical industry makes off of necessary, life-saving drugs used for common illnesses, the moral bankruptcy of a system that rakes in billions of dollars from people being sick, and how the corporate political duopoly upholds such cruelty.

Announcing The Inaugural Informa Pharma Intelligence Awards Japan 2022 by Informa

When we pick up medicine from our nearby chemist, we assume that we are getting what we pay for. That trust may be misplaced. Dinesh Thakur joins Amit Varma in episode 245 of The Seen and the Unseen to share the story of the Ranbaxy fraud, and the shoddy state of Indian pharma today. Also check out: 1. Dinesh Thakur's foundation, blog and Twitter. 2. Bottle of Lies : Ranbaxy and the Dark Side of Indian Pharma -- Katherine Eban. 3. The Impact of Regulatory Structure on Quality of Medicines in India -- Talk by Dinesh Thakur. 4. Dinesh Thakur interviewed by News Laundry, Lallantop and The Accad and Koka Report. 5. The Indian pharmaceutical industry is in denial over drug-quality charges -- Dinesh Thakur. 6. Pharma industry's playbook on low-quality drugs -- Dinesh Thakur and Prashant Reddy Thikkavarapu. 7. India's drug regulator has failed the pandemic stress test -- Dinesh Thakur. 8. In generic drug plants in China and India, data falsification is still a problem -- Katherine Eban and Sony Salzman. 9. Healing the Pharmacy of the World -- KL Sharma. 10. The Gita Press and Hindu Nationalism -- Episode 139 of The Seen and the Unseen (w Akshaya Mukul). 11. Science and Covid-19 -- Episode 221 of The Seen and the Unseen (w Anirban Mahapatra). 12. Slow Ideas -- Atul Gawande. 13. Understanding Indian Healthcare -- Episode 225 of The Seen and the Unseen (w Karthik Muralidharan). 14. The Economics and Politics of Vaccines -- Episode 223 of The Seen and the Unseen (w Ajay Shah). 15. We Must Save Our Farmers -- Amit Varma. 16. ‘Killer cough syrup' maker failed quality tests several times -- Times of India report on the Jammu deaths. 17. Why lethal cough syrup slipped past the law -- Prabha Raghavan and Arun Sharma. 18. COVID-19: Hundreds Of Clinical Trials Under Way In India, Many Lack Rigour, Say Experts -- Anoo Bhuyan. 19. Clinical trial database hole -- GS Mudur. 20. CDSCO faces CIC ire over ‘misplaced' 2013 report on ‘irregular' approval to drugs -- Prabha Raghavan. 21. A Report on Drug Regulator CDSCO's ‘Irregular' Approvals Has Gone ‘Missing' -- The Wire staff. 22. New CDSCO Disclosure Reveals Quality of Medicines Sold in India -- Samir Malhotra. 23. On US blacklist, in India they are in the grey zone -- Ritu Sarin, Kaunain Sheriff M and Jaz Mazoomdar. 24. Poor quality drugs caused Niloufer maternal deaths: Doctors' panel -- Syed Akbar. 25. 2014 Bilaspur tubectomy deaths: Absconding pharma firm director held -- PTI news report. 26. Clinical Trials in India Need Better Regulations -- Shah Alam Khan. 27. Mozambique raises quality concerns on Indian drug exports -- Deepak Patel. 28. Drug regulation: 27 medicines sold by top firms ‘fail' quality tests in seven states -- Deepak Patel. 29. 39 Indian drug companies blacklisted by Vietnam -- Pranshu Rathi. 30. Drugs with carcinogenic toxins: banned elsewhere, sold in India -- Priyanka Pulla. This episode is sponsored by CTQ Compounds. Check out The Daily Reader, FutureStack and The Social Capital Compound. Use the code UNSEEN for Rs 2500 off. Please subscribe to The India Uncut Newsletter. It's free! And check out Amit's online course, The Art of Clear Writing.

Sabrina Oliva is an Exec. Art Producer at FCB Health and is based in NYC. Prior to that role, she freelanced for 15 years with numerous advertising agencies in the NY area, including Publicis, Grey and McCann. She worked on many major beauty and luxury brands such as Loreal, Cadillac and Lexus.   Heather and Sabrina talk about the new rules for attending in-person portfolio shows, her path to becoming an art producer, the producer's role, the challenges of shorter timelines and a reduction in talent, the latest in Covid protocols and what clients are asking for right now. They also predict an increase in productions (especially Pharma) through the end of the year and discuss tips for working with production consultants, treatment fees, the review process and the importance of showing new work.   In an industry where the rules are always changing, it's helpful to hear from those on the front lines. Heather Elder is the visionary behind NotesFromARepsJournal.com; visit HeatherElder.com for industry updates, stunning photography and video, and the artists behind the work. More about our guest: Find Sabrina Oliva on LinkedIn here.  More about your host: Heather Elder's Bio Heather Elder's Blog Heather Elder on Instagram Heather Elder on Twitter Heather Elder on LinkedIn Heather Elder on Facebook

Atyr Pharma has just released the results of a patient trial of a drug called aTyr 1923.  The drug had shown early promise, and the trial more than verified that thinking. Atyr 1923 Not only allowed patients to dose down or even off of Prednisone, but it actually improved lung function in patients -- something that is rarely if ever accomplished. In this episode of the Sarc Fighter podcast, aTyr President and CEO, Dr. Sanjay Shukla joins me to talk about the results, the meaning behind the trial and what happens next, as this leading edge science advances to the next stage, and hopefully to the point where it becomes a solution for so many people in the Sarcoidosis space. Read about the patient trial with aTyr 1923 https://investors.atyrpharma.com/news-releases/news-release-details/atyr-pharma-announces-positive-data-phase-1b2a-clinical-trial Also -- Note that investors also believe in the promise of aTyr 1923: https://investors.atyrpharma.com/news-releases/news-release-details/atyr-pharma-announces-closing-863-million-public-offering   Bonus Episode on COVID-19 and Sarcoidosis https://beatsarc.podbean.com/e/bonus-episode-sarcoidosis-and-covid-19-presented-by-the-foundation-for-sarcoidosis-research/ Bonus Episode  Sarcoidosis and Prednisone: https://beatsarc.podbean.com/e/bonus-episode-sarcoidosis-town-hall-dealing-with-prednisone-presented-by-the-foundation-for-sarcoidosis-research/ MORE FROM JOHN Cycling with Sarcoidosis http://carlinthecyclist.com/category/cycling-with-sarcoidosis/ Watch the Prednisone Town Hall on YouTube https://youtu.be/dNwbcBIyQhE More on aTyr Pharma: https://www.atyrpharma.com/ Do you like the official song for the Sarc Fighter podcast?  It's also an FSR fundraiser! If you would like to donate in honor of Mark Steier and the song, Zombie, Here is a link to his KISS account.  (Kick In to Stop Sarcoidosis)  100-percent of the money goes to the Foundation.  https://stopsarcoidosis.rallybound.org/MarkSteier The Foundation for Sarcoidosis Research https://www.stopsarcoidosis.org/ Donate to my KISS (Kick In to Stop Sarcoidosis) fund for FSR  https://stopsarcoidosis.rallybound.org/JohnCarlinVsSarcoidosis?fbclid=IwAR1g2ap1i1NCp6bQOYEFwOELdNEeclFmmLLcQQOQX_Awub1oe9bcEjK9P1E My story on Television https://www.stopsarcoidosis.org/news-anchor-sarcoidosis/ email me  carlinagency@gmail.com Sarc Fighter Facebook Page  https://www.facebook.com/SarcFighter/ Sarc Fighter on Instagram https://www.instagram.com/thesarcfighter/  

Our guest: Panna Sharma, CEO & President at Lantern Pharma "Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials." In this episode, we discussed: His background Lantern Pharma's why-how-what Biden's drug pricing plan: what's missing and how can we take more steps to reform? What can we expect from the future of AI in cancer treatment? ...and much more! Our sponsors for this episode are BlocHealth, Curation Health, ChenMed & MediTelecare. BlocHealth is building the ecosystem of services and solutions to power the future of healthcare. For more information, please go to www.blochealth.com follow BlocHealth on social media - @blochealth "Curation Health's advanced clinical decision support platform seamlessly integrates into the electronic health record and leverages more than 750 proven clinical and quality rules. With this intelligent point-of-care platform, you can power a scalable risk adjustment process and amplify quality program performance." For more information, please go to www.curationhealthcare.com & follow Curation Health on social media - @curationhealth "ChenMed brings concierge-style medicine and better health outcomes to the neediest populations – moderate-to-low income seniors with complex chronic diseases. For more information, please go to www.chenmed.com & follow ChenMed on social media - @chenmed "MediTelecare provides behavioral telemedicine services to residents of skilled nursing and assisted living facilities, using state-of-the-art telehealth technology. For more information", please go to www.meditelecare.com & follow Meditelecare on social media – @meditelecare To learn more about Lantern Pharma please use the links below: - Website - LinkedIn - Twitter Also, be sure to follow Slice of Healthcare on our social channels: - Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter

The Pfizer-BioNTech vaccine gets Emergency Use Authorization for booster dose in certain individuals; A smaller dose appears safe and effective in children; Janssen share booster data for their vaccine; A survey sheds light on parents' thoughts on child COVID vaccination; Remdesivir efficacy data in COVID-19 patients, And Opzelura is approved for atopic dermatitis.

Check out the most underground podcast in the world, nobody talks about this stuff! Listen to Stevesmi and Ricky V Rock go over steroid topics. In this episode they go over their experiences with 3 of the top brands in the world 1. Alpha Pharma Winstrol - is it injectable too? Masteron 2. Dragon Pharma Helios- Clenbuterol + Yohimbe - Rick discusses this interesting cutter Primobolan Human Growth Hormone 3. Geneza Pharma Trenbolone - Steve talks about why tren is mandatory in bodybuilding Learn more about human growth hormone HGH https://www.evolutionary.org/hgh-human-growth-hormone Discuss Trenbolone https://www.evolutionary.org/trenbolone >>>>>>>>>>>>> for 1 on 1 coaching/consultation/source help requests hit up stevesmi https://www.elitefitness.com/forum/members/stevesmi.html https://www.evolutionary.org/forums/members/stevesmi.html to follow along with RickyV Follow Ricky on Social: http://www.rickyvrock.com/ Follow Ricky and ask him anything: http://www.bigrickrock.com/ Check out the Evolutionary Radio Podcast: https://www.evolutionary.org/podcasts/ Check out the EliteFitness Podcast: https://www.elitefitness.com/articles/podcast

On this episode, Rusty Puttfark does a deep dive into the world of bought-and-paid-for propaganda control of news outlets, big Pharma, big tech and world governments. We play a video of the scripted news media that will blow your mind. You are being controlled and you need to be aware of the actors and agents in this game. We also cover, what a real country who cares about the health of it's citizens, does to mitigate the virus. All this and more on the Free Thinkers Podcast. Free Thinkers Podcast is a show that believes in free speech, original thought and a desire for truth. Follow us on Gab: https://gab.com/puttfark https://gab.com/memejoegreen

Dr. Laura McKain is a board-certified physician with more than ten years of pharmaceutical industry experience. She has experience with clinical-regulatory strategy, study design, protocol writing, Phase 2-4 clinical trials, medical monitoring, safety surveillance, data analysis, and report writing. She received her medical degree from Georgetown University in Washington, DC, and completed her training in obstetrics and gynecology at Virginia Commonwealth University in Richmond, Virginia. She was in private practice for over twelve years where her clinical interests included well-women care, contraception, HPV, menopause management, as well as general and high-risk obstetrics. In 2008 she transitioned her career to the pharmaceutical industry where she was involved in clinical development projects encompassing a broad range of therapeutic areas. She was involved in bringing two new therapeutics to market. She retired from full-time work, recently. She is now focused on helping other physicians to find new nonclinical careers. She does that in several ways. She is a career coach and resumé expert at mckainconsulting.com. And she is the founder of the Physician Nonclinical Career Hunters Facebook Group. Many of you are one of its 17,000 members. It is the premier group where physicians can connect with other physicians, share advice, find job openings, and obtain valuable advice and mentorship about nonclinical careers. Today Dr. McKain describes strategies for finding a pharma job in the area of Clinical Development. To access the show notes and the links for this episode, go to nonclinicalphysicians.com/clinical-development-job. If you'd like to join my Nonclinical Mastermind Group, you can learn about it at nonclinicalphysicians.com/mastermind. Get an updated edition of the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs. Check out a FREE WEBINAR called Best Options for an Interesting and Secure Nonclinical Job at nonclinicalphysicians.com/freewebinar1

Russell (Russ) Gong, co-founder of sustainability healthcare brand Cabinet. Russ is a former social entrepreneur and US National Guard, Infantry who also worked in community empowerment. The Cabinet Health brand was born as a result of his vision for a more transparent and sustainable healthcare. Building a sustainable direct-to-consumer pharma brand the right way is not an easy task, but it's today's only option. At the same time, healthcare is impersonal and it shouldn't be. OTC and pharmacies are very confusing - people wander down the aisles unsure of what to purchase - it shouldn't be this way and there are new generation entrepreneurs already tackling the challenge. Here in Episode #136, Russ starts our show with a leadership mindset to persevere through your growth mindset. Russ gives us a great overview of how he brings quality, sustainability, and personal care into every aspect of his startup organization, Cabinet. He shares insights into the personal and professional goals that drive his mission-centered career. Russ highlights how his entrepreneurial journey has deepened his personal resolve for succeeding. Russ gives us critical areas of focus that healthcare leadership have on their radar for achieving more sustainable solutions in healthcare; and adds insights on our responsibilities for protecting the environment. Russ breaks down the highest highs and lowest lows while leading his organization. He gives a huge shout-out to the healthcare leaders that have impacted his journey. Russ breaks down the number one challenge and opportunities for emerging healthcare leaders and highlights a business opportunity for professionals looking into the world of sustainable operations. And Russ gives us a straight shot leadership mindset with no hidden contracts. • Connect with Russel on LinkedIn • Learn More About Cabinet Health • Access the Healthcare QualityCast LinkedIn Group • Leaves Us a Rating --- Send in a voice message: https://anchor.fm/healthcarequalitycast/message

Pfizer got FDA approval then what? NURO was a big hit for a few days, now what? TNXP had to pivot from its Fibromyalgia drug, now what? Check out the current status of these stocks to determine if they are worth the investment or not!3 Pharma Stocks to Buy Now? PFE - TNXP - NURO | VectorVestUse this link for a FREE Stock Analysis Report ➥➥➥ http://bit.ly/2KsZlqzTry VectorVest Risk-Free for 30 Days ➥➥➥ https://www.vectorvest.com/YTVectorVest mobile app ➥➥➥ http://bit.ly/2UjF6y6 SUBSCRIBE To The VectorVest Channel ➥➥➥ https://www.youtube.com/user/VectorVestMB/?sub_confirmation=1

Become a Founding Member to the Future Generations Community: https://thefuturegen.com/community Join our email list here: http://thefuturegen.com Get your copy of the Heart of Freedom 2 recordings here Remember to Rate, Review and Subscribe on iTunes and Follow us on Spotify Follow us on Instagram: @futuregenpodcast In this episode, Dr. Dale Brown establishes the clearest relationship between these pharma companies and the deepest, darkest and most nefarious agendas. Dr. Brown is a beacon of TRUTH and committed to spreading it as far and wide as possible. Dr. Dale has been serving his community as a chiropractor for 11 years, he is a holistic health coach/advocate and he's very passionate about healing our bodies in an innate manner. He has been serving the Clarksville / Ft. Campbell area since 2010. In that time, he's had the opportunity to work with local educators at the primary school and university levels. He has also been able to serve our fighting men and women of the 101st Airborne Division (Air Assault) along with their families. He is a current board member for S.A.F.E. (Soldier and Families Embraced), a non-profit organization that offers individual and group counseling services, as well as peer support groups for active duty, veterans, and their families.   Stay Connected with Dr. Dale Brown: https://thewilddoc.com/ Subscribe to his newsletter here Instagram: https://www.instagram.com/thewilddoc/ ______________________________ Stay Connected with the Future Generations Podcast: Instagram: @futuregenpodcast, @thefuturegensd and @drstantonhom_ Facebook: Future Generations Podcast and Future Generations | Clinic of Chiropractic Website: Future Generations | Clinic of Chiropractic Remember to Rate, Review and Subscribe on iTunes and Follow us on Spotify!

Pharma's ‘Natural Immunity' Problem; Jeffery and Del Deconstruct Biden's Misinformed Address to the Nation; Exclusive Interview with Respected Hospitalist PA Exposes Potential Massive Fraud on the Frontlines; NY Protesters send message, “It's Time to Make a Stand.”Guest: Deborah Conrad, PA-C

John Paul Rice - Film maker, Producer joins us to chat about sacred children, dark consolidated Hollywood and finding alternative solutions. We have a great chat about authentic truth, defending vs. Fighting, split in consciousness, human trafficking and mass psychology.   We talk about creating ripples, NWO, big Pharma, satanism, distractions, parenting, responsibilities, soul/spirit, the light and dark, pursuing meaning, the transhumanist agenda, the 4th industrial revolution, going within, fear of dying and scaling away your dependancy on tech.   In the second half we get into idol worship, hyper sexualization, no more political solutions, the peaceful path, a Childs Voice, priorities, ritual abuse, truthful art, Standing up for truth, tapping, EFT, the future of Hollywood, social media and the symbolism, open source data, Q, #save the children, and PTSD.   A Child's Voice https://vimeo.com/ondemand/achildsvoice Game Day https://www.gofundme.com/GameDayMovie Connect https://linktr.ee/NoRestrictions   See links to stuff we chatted about during the show:   https://www.goodreads.com/book/show/662.Atlas_Shrugged   https://www.coreysdigs.com/?__cf_chl_jschl_tk__=pmd_foCCJTnzVWNcWu5_Cf1haCsr10MFzFyUo5..TfejQgM-1631895745-0-gqNtZGzNAdCjcnBszQhR   https://www.unitedpeople-foundation.org/en   How Does Havening Work? https://youtu.be/gqIL8dXB7b0 Paul McKenna Official | The Havening Technique  https://youtu.be/09IDxrXAi2s EFT tapping (various sources)  https://www.youtube.com/results?search_query=EFT+tapping Matrix Reimprinting using EFT: Rewrite Your Past, Transform Your Future by Karl Dawson and Sasha Allen https://www.amazon.com/Matrix-Reimprinting-using-EFT-Transform/dp/1848502494 What is Matrix Reimprinting?  https://www.matrixreimprinting.com/what-is-matrix.aspx The Roots of Violence by Alice Miller  https://www.alice-miller.com/en/the-roots-of-violence The Roots of Violence are Not Unknown  http://www.alice-miller.com/en/the-roots-of-violence-are-not-unknown/3 Drama of the Gifted Child by Alice Miller  https://www.amazon.com/Drama-Gifted-Child-Search-Revised/dp/0465016901 For Your Own Good: Hidden Cruelty in Child-Rearing and the Roots of Violence by Alice Miller  https://www.amazon.com/Your-Own-Good-Child-Rearing-Violence/dp/0374522693 The Body Never Lies: The Lingering Effects of Hurtful Parenting by Alice Miller  https://www.amazon.com/Body-Never-Lies-Lingering-Parenting/dp/0393328635   https://www.ted.com/playlists/289/the_genius_of_babies   https://www.amazon.com/Master-His-Emissary-Divided-Western/dp/0300188374   https://www.savetheredwoods.org/blog/book-reading-the-giving-tree-by-shel-silverstein/   https://sagaciousnewsnetwork.net/the-mass-psychology-of-totalitarianism/   https://sarahwestall.com/the-globalist-agenda-the-covid-plandemic-is-just-the-beginning/   https://havening.org/   Thank you for your support.  To gain access to the second half of show and our Plus feed please clink the link http://www.grimericaoutlawed.ca/support. Help support the show because without your help we can't continue to address these controversial topics. If you value this content with 0 ads, 0 sponsorships, 0 breaks, 0 portals and links to corporate websites, please assist. Many hours of unlimited content for free. Thanks for listening!!   Support the show directly: https://www.patreon.com/grimericaoutlawed   Get your Magic Mushrooms delivered from: Mushroom Spores, Spore Syringes, Best Spore Syringes,Grow Mushrooms   Spores Lab   Get Psychedelics online   Our audio book page: www.adultbrain.ca Darren's book www.acanadianshame.ca   Other affiliated shows: https://www.13questionspodcast.com/ Our New Podcast - 13 Questions www.grimerica.ca The OG Grimerica Show www.Rokfin.com/Grimerica Our channel on free speech Rokfin   Join the chat / hangout with a bunch of fellow Grimerican's  www.grimerica.ca/chats   1-403-702-6083 Call and leave a voice mail or send us a text   GrimericaFM https://s2.radio.co/s053ed3122/listen Check out our next trip/conference/meetup - Contact at the Cabin www.contactatthecabin.com   Leave a review on iTunes and/or Stitcher: https://itunes.apple.com/ca/podcast/grimerica-outlawed http://www.stitcher.com/podcast/grimerica-outlawed   Sign up for our newsletter http://www.grimerica.ca/news   SPAM Graham = and send him your synchronicities, feedback, strange experiences and psychedelic trip reports!! graham@grimerica.com InstaGRAM https://www.instagram.com/the_grimerica_show_podcast/    Tweet Darren https://twitter.com/Grimerica   Connect through other platforms: https://www.reddit.com/r/grimerica/  https://gab.ai/Grimerica    Purchase swag, with partial proceeds donated to the show www.grimerica.ca/swag Send us a postcard or letter http://www.grimerica.ca/contact/ ART Napolean Duheme's site http://www.lostbreadcomic.com/  MUSIC Tru North Felix's Site sirfelix.bandcamp.com  

See the full interview at http://usefulidiots.substack.com “The charade of statesmanship played out by George W. Bush and his enabler, Condoleezza Rice, as they wander the Middle East is a fitting end to seven years of misrule, stripped of power and transformed from monsters into buffoons. One half expects to see him stand up at the next president's inauguration and screech ‘I'm melting! I'm melting!' as he sinks into a puddle of slime.” This was penned by friend-of-show and Pulitzer Prize-winning journalist Chris Hedges back in 2008. And at the time, it seemed to reflect the opinion of George W. Bush among Leftists and Liberals. But now, he's back. Liberals who used to condemn him now love him! He hangs out with Obama, he gives speeches denouncing Trump, he paints! Now that's a thoughtful and cultured war criminal with whom we'd like to grab a Sauvignon blanc. In addition to blasting the grotesque rehabilitation of Dubya, Hedges shares his experience of 9/11 which he witnessed in New York City where he happened to be for a meeting with his then-employer The New York Times. He recalls those who jumped from the buildings who were edited out because “that mass suicide just didn't fit the narrative that both the media and the ruling elites were propelling.” When we asked him if 9/11 surprised him after years of serving and reporting in the Middle East, watching US bombs fall on cities, he responded, “That is how we communicate with the rest of the world. Huge explosions and death above a city skyline. That's how we have communicated for decades. And the hijackers learned to communicate back to us in the language we taught them. So when I saw the devastation, it was familiar. That was of course lost on most of the public who drank deep from that very dark elixir of nationalism.” Plus, the new Useful Idiots Wigged Moose Party announces a plan to ride in an armored pangolin and shoot Covid pellets at the Pharma companies refusing to share the vaccine. Maybe you have to see it to get it. It's all this, and more (including a #JacoOfTheWeek), on this week's episode of Useful Idiots. Check it out. And don't forget to subscribe to hear the rest of the interview with Chris Hedges, which drops Monday.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Charles Mackenzie is the administrator of the Tainted Blood Product Action Group, and he says an estimated 20,000 Australians have been infected with Hepatitis C through contaminated blood products. This massive scandal has led him into a 30-year fight for justice on behalf of Australian victims as well as other victims of tainted blood products across the world. For more information on Charles, please visit: https://www.infectedbloodaustralia.com/news-1 Health Freedom for Humanity is facing unprecedented levels of censorship. We have been deplatformed from multiple social media sites, YouTube, eventbrite, etc.. We rely on contributions from our community members, listeners, and followers. If you would like to donate to HFfH to ensure we're able to keep educating, empowering, and uniting humanity, please visit https://www.healthfreedomforhumanity.org/donate

In this Pharma Outcomes Rocket episode, we are privileged to have two special guests. Naomi Fried is the founder and CEO of Pharmstars and Laura Gunn is the Managing Director of Pharmstars, the first pharma-focused accelerator for digital health startups. Naomi and Laura discuss how Pharmstars address the gap between pharma manufacturers and startups. They share how the accelerator educates and mentors startups, how it facilitates and accelerates successful partnerships, how it reduces the gap between pharma and digital health startups, and more. They also talk of the Pharmstars leverage as the only accelerator in the space with a comprehensive curriculum that's built and tailored for digital health startups that want to work with pharma. If you are a startup looking to learn more about pharma or a pharma manufacturer looking to improve your digital health innovations, this interview is for you. Please tune in! Click this link to the show notes, transcript, and resources: outcomesrocket.health

Subscribe: RSS Visit melissavogelfitness.com/course for the free email course. What exactly are hormones doing in our body? What are the types of hormones and their jobs? Why is testosterone important to the female body? And, why are we being prescribed medications when hormones could be the answer? In this podcast, I speak with Dr. Angela… The post Health, Hormones and Pharma with Dr. Angela DeRosa |83 appeared first on Melissa Vogel.

Here's the cold hard truth: The whole specialty pharmacy operational model is not built to serve patients, a fact that becomes crystal clear when you're a patient. Instead, the specialty pharmacy model is, rather, pretty blatantly dedicated to the power struggle for revenue and captive patient populations. It's war between providers and the whole PBM/insurer/specialty pharmacy vertical consolidations. Employers and pharma manufacturers are, of course, on the battlefield as well. The patient, meanwhile, gets to be more the product than the customer if you think about. It's probably more similar than anyone would like to admit to the way that Facebook or Twitter users are the product, not the customer. This analog is not entirely parallel, but there's unsettling similarities if you think about it. What is a drug that qualifies to be a specialty pharmacy drug? Usually, these drugs are complicated to store, dispense, to use, and/or they're expensive—generally, really expensive. Lots of zeros, completely unaffordable to pay cash for them as an individual. No one is using a GoodRx card and not using their insurance to pay for these puppies. They can cost as much as a house. Biologics, for example, usually considered specialty drugs—lots of cancer and immunology therapies, injectable medications, IV/infused medications—all these are usually considered specialty drugs. There's no one definition of a specialty drug. It's more that someone somewhere decided to not run the drug through your traditional retail pharmacy for any number of reasons. The problem with the current status quo, wherein the patient gets tossed around while everybody fights over them, is that some basic needs are not being met—like if a patient asks the person administering the drug maybe even a pretty simple question about the drug or its side effects. It's way more likely than it should be that the nurse or whomever doesn't know the answer. Not knocking nurses here at all but definitely knocking a system that allows that to happen. I mean, really now. We're injecting a six-figure therapy in someone's arm that will impact their body in a myriad of maybe frightening ways, some of which are a problem and some of which are not. Said another way, there's a really good financial and clinical use case for making sure that we're patient-centric at a specialty pharmacy point of service—if you care about the patient and cost efficiency, that is. But I guess therein lies the root cause of the trouble. In this healthcare podcast, I'm talking with Olivia Webb about what it would take and be like to create a “patient-first specialty pharmacy,” as she has coined the term—a specialty pharmacy dedicated to patients not only having a half-decent experience but also one that might actually create better patient outcomes. Olivia Webb is author of the Acute Condition newsletter. I would certainly recommend subscribing. Coming up, we're doing a few more shows on this topic wherein we cover the whole brown bagging, white bagging, clear bagging extravaganza. Also, hospitals opening up their own PBMs, which is a fascinating wrinkle. One last thing: If you're following the whole PBM/insurer/specialty pharmacy vertical integration skullduggery, keep an eye on a bunch of lawsuits against these combined entities (three examples here, here, and here) alleging that they are doing some not super upright and honest things with their massive market power. (Say it isn't so!) You can learn more at acutecondition.com. Olivia Webb, PharmD, is a healthcare strategist and writer. She publishes the weekly healthcare newsletter Acute Condition, in addition to writing freelance pieces. She also works as a senior communications manager at the specialty care start-up Thirty Madison. In the past, Olivia has worked on healthcare policy and hospital consulting at Economic Liberties, Massachusetts General Hospital, and Advisory Board Company.   04:11 Why did Olivia start thinking about a patient-centric specialty pharmacy? 05:33 “There's really no layer on top of it to make it look nice.” 06:23 “You're kind of dealing with this vertical stack that doesn't really deal with patients frequently.” 06:35 Is the specialty model more patient friendly or less? 07:08 What would a patient-centric specialty pharmacy look like? 07:58 “There's a lot of fragmentation; there's a lot of friction.” 08:11 What's unique to specialty pharmacy prescriptions? 10:38 Why can infusion centers be a high-drama place? 12:15 What's “the question” around specialty pharmacy? 12:42 Who has the vested interest in ensuring patients take their medications correctly in specialty pharmacy? 14:39 “It's really just a unique area of healthcare where the people that I think of as the good guys and the bad guys completely flips.” 16:05 Why might the time be ripe for disruption in the specialty pharmacy area? 19:56 “There's no one with a clear incentive to cap the prices.” 20:09 What are the barriers in specialty pharmacy? 20:31 “The patient just isn't at the center, the financial incentive, in any direction.” 29:22 “I think people who are designing these things need to see how patients are actually doing it.” 29:50 “I think there's a lot of money here; I think this market is going to only increase in size.” 30:10 “I think you need scale.” 30:20 AEE15 with David Carmouche, MD, of Ochsner. You can learn more at acutecondition.com.   @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth Why did Olivia start thinking about a patient-centric specialty pharmacy? @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth “There's really no layer on top of it to make it look nice.” @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth “You're kind of dealing with this vertical stack that doesn't really deal with patients frequently.” @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth Is the specialty model more patient friendly or less? @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth What would a patient-centric specialty pharmacy look like? @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth “There's a lot of fragmentation; there's a lot of friction.” @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth What's unique to specialty pharmacy prescriptions? @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth Why can infusion centers be a high-drama place? @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth What's “the question” around specialty pharmacy? @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth Why might the time be ripe for disruption in the specialty pharmacy area? @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth “It's really just a unique area of healthcare where the people that I think of as the good guys and the bad guys completely flips.” @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth “The patient just isn't at the center, the financial incentive, in any direction.” @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth “I think people who are designing these things need to see how patients are actually doing it.” @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth “I think there's a lot of money here; I think this market is going to only increase in size.” @OliviaWebbC of @thirtymadison and the #acutecondition newsletter discusses #patientfirst #specialty on our #healthcarepodcast. #healthcare #podcast #digitalhealth Recent past interviews: Click a guest's name for their latest RHV episode! Brandon Weber, Stacey Richter (INBW30), Brian Klepper (AEE16), Brian Klepper (EP335), Sunita Desai, Care Plans vs Real World (EP333), Dr Tony DiGioia, Al Lewis, John Marchica, Joe Connolly, Marshall Allen, Andrew Eye, Naomi Fried, Dr Rishi Wadhera, Dr Mai Pham, Nicole Bradberry and Kelly Conroy, Lee Lewis, Dr Arshad Rahim, Dr Monica Lypson, Dr Rich Klasco, Dr David Carmouche (AEE15), Christian Milaster, Dr Grace Terrell, Troy Larsgard, Josh LaRosa, Dr David Carmouche (EP316), Bob Matthews, Dr Douglas Eby (AEE14)

We talk to Carol Lynch, Chief Business Officer, Sandoz, about how to increase the number of women in leadership positions in the pharmaceutical industry, the importance of mental health provisions in the workplace, and Sandoz's role in increasing access to biosimilars around the world.

Grant Johnson is the Founder and CEO of Responsory, a full-service marketing communications agency focused on providing measurable marketing solutions to B2B, B2C, and not-for-profit organizations. Their process combines data, AI, and testing to deliver multi-channel marketing campaigns to make their clients heroes — and ultimately get them ROI. Grant started Responsory in 1999 but has been in the agency world since 1988. When people ask Grant what he does, he says, “I'm a drug dealer.” That's because Grant has marketed products in the Pharma, Vitamins, and Nutraceuticals industry. His expertise also cuts across the insurance and B2B products marketing space.  Grant is a sought-after public speaker, direct marketing trainer, copywriter, award-winning author, and the creator of Direct BrandingSM, Responsory's method for producing sure-fire measurable results. He's helped companies like Humana, Northwestern Mutual, Microsoft, and many more. In this episode… What does a “drug dealer” have to do with B2B marketing strategies, and what can you learn from them? Well, we're talking about “drug dealers” in the sense of Pharma, Vitamins, and Nutraceuticals. And we're going to take you on a journey of how Grant Johnson, Founder and CEO of Responsory, creates effective marketing campaigns.  He breaks everything down — from research to data gathering, testing, creatives, landing pages, and result tracking. If you've ever been intrigued by the magic of direct response marketing, you'll love every bit of this episode! On this episode of the Inspired Insider Podcast with Dr. Jeremy Weisz featuring Grant Johnson, Founder and CEO of Responsory, you'll go behind the scenes of dimensional direct mail marketing that works, the role of imagery and landing pages, and why data, testing, and measurability makes all the difference.

We go over the money mindset, how to make money on an upcoming inevitable stock split in amazon and the money mindset --- Support this podcast: https://anchor.fm/tallguytycoon/support

This week we have news on pediatric influenza vaccine guidance; Moderna submit data for their COVID-19 booster dose; There's new FDA warnings for some JAK inhibitors; Trudhesa nasal spray is approved; And the FDA places a clinical hold on a gene therapy for phenylketonuria.

Tune in to E.136 featuring Tim Schlidt, Co-Founder and partner at Palo Santo as we discuss investing in psychedelics. Palo Santo's diversified investment fund is helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions in today's world. We discuss the rising mental health conditions facing people around the world and how psychedelics are well positioned to address this problem. Tim also explains how many of the companies in Palo Santo's portfolio are taking an authentic and innovative approach to healthcare. We have an in-depth conversation about big Pharma's role in this evolution and the idea of synthetically deriving these compounds. Tim explains what the implications of this will be for both patients as well as the indigenous communities who utilize these compounds for ceremonial purposes. The show wraps up discussing some of the creative work these companies are producing in the field and where the future of psychedelics might be in the next 5-10 years. If you are looking to learn more about the future of investing in psychedelics give this episode a listen! --- Support this podcast: https://anchor.fm/lit-and-lucid/support

We have moved past the time when pills and medications are the only sources of treatment. The increasing demand for digital treatments and supplemental services shows the need for pharma manufacturing companies to be willing to let go of the "traditional" models and embrace new solutions. In this episode, we are privileged to host Amy West, head of U.S. Digital Transformation & Innovation at Novo Nordisk. Amy discusses Novo Nordisk's vision of identifying the true pain point of end-users and developing solutions to meet the needs of customers beyond pharmacotherapy. She shares how innovations in tech touch pharma and reasons why pharmaceutical companies should move beyond the pill. She emphasizes the importance of taking a patient-centric approach to deliver value and discusses some examples of wraparound services to address challenges. This is a fascinating conversation you don't want to miss! Click this link to the show notes, transcript, and resources: outcomesrocket.health

Today we have Capt. Ryan Sweeney (@captain_ryan_sweeney) a USCG licensed boat captain out of San Diego who loves spearfishing. If you're in SD and want to hop on a boat, hit him up for fishing, spearfishing, or cruising adventures! We cover: Who he is How he got into captaining Tips for preventing seasickness Check out more from Cast & Spear: Subscribe to the Cast & Spear Podcast Check out our Weekly Fishing Newsletter Watch our YouTube videos Follow our Instagram Watch our TikTok videos Like our Facebook Page

This week's challenge: Make some unreasonable death demands.You can hear the after show and support Do By Friday on Patreon!------Edited by Quinn RoseEngineered by Cameron Bopp------Show LinksFleetwood Mac - "Tusk" (Official Music Video) - YouTubeWebstock '11: Marco Arment - Contrary to popular belief on VimeoWebstock '11: Merlin Mann - Scared Shitless: How I Learned to Love Being Afraid of Pretty MuchApple walks back controversial Safari changes with iOS 15 beta 6 update – TechCrunchOrganizing Chaos — On the Media — OvercastWhy Fish Don't Exist: A Story of Loss, Love, and the Hidden Order of LifeNo Such Thing As A Fish | NosuchthingasafishJohn Mulaney Tells Seth About His Eventful YearVivaldi Browser | Now with built-in Translate, Mail, and CalendarAmazonSmile: Brightline Bags Flex B7 Flight Preconfigured Modular Bag : ElectronicsAero Nerd's Brightline Flight Bag Review (Best Ever?) - YouTubeFrank Abagnale - WikipediaFrank Abagnale | Catch Me If You Can | Talks at Google - YouTubeNo Such Thing As A Fish | NosuchthingasafishLichens!CrocsBody FarmThe PrestigeExit 57The StateThe Whitest Kids U' KnowKids in the HallDavid Wain on Mac Power Users:Mac Power Users #50: Workflows with David Wain - Relay FMMac Power Users #147: David Wain Returns - Relay FMMac Power Users #267: David Wain's Film and Television Workflows - Relay FMMac Power Users #525: Workflows with David Wain - Relay FMWet Hot American SummerFive requests with regard to my eventual death | 5ivesNext week's challenge: Watch The Other Two.

Should you speak up in meetings? How do you speak confidently in meetings, or get over your fear of talking in meetings? Many aspiring leaders hesitate to speak up in work meetings, afraid of not having the right thing to say. And yet, your professional visibility and perceived leadership potential depends on this. If you know your thought leadership could use a boost, this episode is for you.In this episode of The Career Rx we'll discuss:Presenting the right information at the right timeHow to deliver uncomfortable information smoothlyWhat to do when you don't have the answerToday's episode covers seven tips for speaking up with executive presence that you'll be able to apply to your professional circumstances, no matter your career. This is inspired by a group session at one of my regular Women Physicians in Pharma networking chats, and I've curated the best advice right here to share with you. By the end of this episode, you'll know how to speak up in a way that enhances your leadership, have the confidence to speak up so that you're both recognized and respected, and be ready for the mindset shift that you don't actually need all the answers.In this Episode: [1:10] Why are you in the room in the first place? Anchor on this...[4:50] Tell people what they need to know (not everything YOU know)[5:23] What to say when you actually don't know the answer[7:45] Smart ways to deliver a dissenting or unpopular opinion[10:55] Nix the apology! Often used as a transitional phrase, but leaders never do this[14:15] Connecting the conversation to the bigger picture may be the best tacticLinks and Resources: Want to join the Women Physicians in Industry Networking Group? Start here.  

Barron's senior managing editor Lauren R. Rublin and healthcare industry reporter Josh Nathan-Kazis discuss the outlook for healthcare stocks and the Covid pandemic.

Augmented reveals the stories behind the new era of industrial operations, where technology will restore the agility of frontline workers. In episode 31 of the podcast, the topic is: Pharma 4.0. Our guest is Michelle Vuolo, Quality Practice Lead, Tulip.In this conversation, we talk about GxP, the collection of quality guidelines and regulations created to ensure that bio/pharmaceutical products are safe, meet their intended use, and adhere to quality processes during manufacturing, control, storage, and distribution, specifically in the context of emerging digital technologies that promise to improve efficiency, so-called industry 4.0 or, in this case, pharma 4.0 technologies.Augmented is a podcast for industry leaders and operators, hosted by futurist Trond Arne Undheim (@trondau), presented by Tulip.co, the frontline operations platform, and associated with MFG.works, the industrial upskilling community launched at the World Economic Forum. Each episode dives deep into a contemporary topic of concern across the industry and airs at 9 am US Eastern Time every Wednesday. Augmented--the industry 4.0 podcast--industrial conversations that matter.After listening to this episode, check out:Tulip: https://tulip.co/Michelle Vuolo: https://www.linkedin.com/in/mtullie/Trond's takeaway: Pharma 4.0 has to be executed with a diligence unseen in the software industry, which also explains why change has taken a while to come to pass. Now that the industry is taking on board the promise of such technologies, it also has to document its effects. The impact on digital technologies should be positive although it will not be without frustrations for those who want quick wins.Thanks for listening. If you liked the show, subscribe at Augmentedpodcast.co or in your preferred podcast player, and rate us with five stars. If you liked this episode, you might also like episode 33, Sustainable Manufacturing at Scale, episode 23, Digital Manufacturing in the Cloud, or episode 17, Smart Manufacturing for All. Augmented--industrial conversations that matter.

Hubwonk host Joe Selvaggi talks with Pioneer Institute Visiting Fellow in Life Sciences Dr. William Smith about how the price control features of the emerging $3.5 trillion infrastructure bill might affect the pharmaceutical Industry, both nationwide and here in Massachusetts, and what effect that change will have on drug consumers. Guest: William S. Smith is Visiting Fellow in […]

Gizelle talks about her first jobs, including taking doctors to strip clubs as a pharmaceutical rep! Clipped from Episode 13: "Jobs Are Us"  Get in touch with the show: whatsup@reasonablyshady.com  Follow Robyn on IG: robyndixon10  Follow Gizelle on IG: gizellebryant Learn more about your ad-choices at https://www.iheartpodcastnetwork.com